Find the latest oncology news for your sub-specialty area
Drugs that target a receptor on immune cells called activin receptor 1C may combat tumour-induced…
Cell therapies for cancer can be potentially enhanced using a CRISPR RNA-editing platform, according to…
The National Institutes of Health (NIH) has launched a clinical trials network to evaluate emerging…
A breakthrough class of molecular glue identified at the University of Dundee, Scotland, could pave…
Annual breast cancer screening beginning at age 40 and continuing to at least age 79…
An innovative computer model of a human lung is helping scientists simulate, for the first…
A specific combination of targeted therapy and immunotherapy may better help patients with non-small cell lung cancer (NSCLC) overcome inherent immune…
Patients with soft-tissue sarcoma treated with neoadjuvant, or pre-surgical, immunotherapy had very little residual tumour at the time of…
A new, cutting-edge study from the University of Ottawa (uOttawa), Canada, has found vanoxerine, a…
A new partnership between a Pennington Biomedical physician-researcher at the Metamor Institute and an LSU…